0.01Open0.01Pre Close0 Volume37 Open Interest880.00Strike Price0.00Turnover78.09%IV34.61%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0006Delta0.0000Gamma65376.00Leverage Ratio-0.0081Theta0.0001Rho41.97Eff Leverage0.0017Vega
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o